To test this possibility, we identified four representative T/NK modules that tracked with survival differences in distinct tumor types (FOXP3.mod, PDCD1.mod, FLT3LG.mod and KLRB1.mod for bladder, head and neck, kidney and melanoma, respectively (Table 2)). This evidence concerns the gene FLT3LG and neoplasm.